| William M Handy Md Pc | |
|
389 Falls Dr Nw Abingdon VA 24210-8093 | |
| (276) 623-0740 | |
| (276) 623-0660 |
| Full Name | William M Handy Md Pc |
|---|---|
| Speciality | Family Medicine |
| Location | 389 Falls Dr Nw, Abingdon, Virginia |
| Authorized Official Name and Position | William Mark Handy (OWNER) |
| Authorized Official Contact | 2766230740 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| William M Handy Md Pc 389 Falls Dr Nw Abingdon VA 24210-8093 Ph: (276) 623-0740 | William M Handy Md Pc 389 Falls Dr Nw Abingdon VA 24210-8093 Ph: (276) 623-0740 |
| NPI Number | 1538255542 |
|---|---|
| Provider Enumeration Date | 10/05/2006 |
| Last Update Date | 12/21/2015 |
| Medicare PECOS PAC ID | 7810910205 |
|---|---|
| Medicare Enrollment ID | O20060111001190 |
News Archive
Academic and Community Cancer Research United (ACCRU) today announced the opening of a two-arm, randomized phase III, FDA registration trial of eribulin compared to standard weekly paclitaxel as first- or second-line chemotherapy for individuals with human epidermal growth factor receptor 2 (HER2) negative, locally recurrent, unresectable or metastatic breast cancer.
Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that there was a successful auction sale of five drug program intellectual properties on September 30, 2009.
Only one in three women participating in Germany's mammography screening programme (MSP) is well-informed about it: the higher the level of education, the greater the chance of women making an informed decision.
A combination of visual training and a recently developed brain stimulation technique boosts learning in healthy adults and cortically blind patients, according to research published in JNeurosci.
In this post in the Public Health Institute's "Dialogue4Health" blog, Jeffrey Meer, director of PHI's Washington-based advocacy on global health, writes that "a significant expansion of PEPFAR's existing work to combat cervical cancer" through a partnership with the George W. Bush Institute known as Pink Ribbon Red Ribbon (PRRR); a 50 percent increase in the U.S. government's "commitment to screen and treat for this type of cancer from $20 million over five years to $30 million"; and additional funding from Susan G. Komen for the Cure "to expand breast cancer awareness and prevention among the same target population of women receiving care at PEPFAR-funded HIV service sites" has allowed "the wonderfully robust PEPFAR prevention and treatment platform, considered one of the great global health achievements in recent times, to be made available to a whole new type of prevention - in this case for a non-communicable disease (NCD)."
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538255542 | NPI | - | NPPES |
| DE1243 | Other | VA | RR MCR GROUP |
| 187201 | Other | VA | ANTHEM BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101050255 (Virginia) | Primary |
| Provider Name | William Mark Handy |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1124017744 PECOS PAC ID: 5991728388 Enrollment ID: I20060111001199 |
News Archive
Academic and Community Cancer Research United (ACCRU) today announced the opening of a two-arm, randomized phase III, FDA registration trial of eribulin compared to standard weekly paclitaxel as first- or second-line chemotherapy for individuals with human epidermal growth factor receptor 2 (HER2) negative, locally recurrent, unresectable or metastatic breast cancer.
Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that there was a successful auction sale of five drug program intellectual properties on September 30, 2009.
Only one in three women participating in Germany's mammography screening programme (MSP) is well-informed about it: the higher the level of education, the greater the chance of women making an informed decision.
A combination of visual training and a recently developed brain stimulation technique boosts learning in healthy adults and cortically blind patients, according to research published in JNeurosci.
In this post in the Public Health Institute's "Dialogue4Health" blog, Jeffrey Meer, director of PHI's Washington-based advocacy on global health, writes that "a significant expansion of PEPFAR's existing work to combat cervical cancer" through a partnership with the George W. Bush Institute known as Pink Ribbon Red Ribbon (PRRR); a 50 percent increase in the U.S. government's "commitment to screen and treat for this type of cancer from $20 million over five years to $30 million"; and additional funding from Susan G. Komen for the Cure "to expand breast cancer awareness and prevention among the same target population of women receiving care at PEPFAR-funded HIV service sites" has allowed "the wonderfully robust PEPFAR prevention and treatment platform, considered one of the great global health achievements in recent times, to be made available to a whole new type of prevention - in this case for a non-communicable disease (NCD)."
› Verified 2 days ago
| Provider Name | Jennifer C Widener |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568802338 PECOS PAC ID: 7214170786 Enrollment ID: I20130904000154 |
News Archive
Academic and Community Cancer Research United (ACCRU) today announced the opening of a two-arm, randomized phase III, FDA registration trial of eribulin compared to standard weekly paclitaxel as first- or second-line chemotherapy for individuals with human epidermal growth factor receptor 2 (HER2) negative, locally recurrent, unresectable or metastatic breast cancer.
Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that there was a successful auction sale of five drug program intellectual properties on September 30, 2009.
Only one in three women participating in Germany's mammography screening programme (MSP) is well-informed about it: the higher the level of education, the greater the chance of women making an informed decision.
A combination of visual training and a recently developed brain stimulation technique boosts learning in healthy adults and cortically blind patients, according to research published in JNeurosci.
In this post in the Public Health Institute's "Dialogue4Health" blog, Jeffrey Meer, director of PHI's Washington-based advocacy on global health, writes that "a significant expansion of PEPFAR's existing work to combat cervical cancer" through a partnership with the George W. Bush Institute known as Pink Ribbon Red Ribbon (PRRR); a 50 percent increase in the U.S. government's "commitment to screen and treat for this type of cancer from $20 million over five years to $30 million"; and additional funding from Susan G. Komen for the Cure "to expand breast cancer awareness and prevention among the same target population of women receiving care at PEPFAR-funded HIV service sites" has allowed "the wonderfully robust PEPFAR prevention and treatment platform, considered one of the great global health achievements in recent times, to be made available to a whole new type of prevention - in this case for a non-communicable disease (NCD)."
› Verified 2 days ago
| Provider Name | Nicholas B Maddox |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609584960 PECOS PAC ID: 1355716291 Enrollment ID: I20230407000525 |
News Archive
Academic and Community Cancer Research United (ACCRU) today announced the opening of a two-arm, randomized phase III, FDA registration trial of eribulin compared to standard weekly paclitaxel as first- or second-line chemotherapy for individuals with human epidermal growth factor receptor 2 (HER2) negative, locally recurrent, unresectable or metastatic breast cancer.
Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that there was a successful auction sale of five drug program intellectual properties on September 30, 2009.
Only one in three women participating in Germany's mammography screening programme (MSP) is well-informed about it: the higher the level of education, the greater the chance of women making an informed decision.
A combination of visual training and a recently developed brain stimulation technique boosts learning in healthy adults and cortically blind patients, according to research published in JNeurosci.
In this post in the Public Health Institute's "Dialogue4Health" blog, Jeffrey Meer, director of PHI's Washington-based advocacy on global health, writes that "a significant expansion of PEPFAR's existing work to combat cervical cancer" through a partnership with the George W. Bush Institute known as Pink Ribbon Red Ribbon (PRRR); a 50 percent increase in the U.S. government's "commitment to screen and treat for this type of cancer from $20 million over five years to $30 million"; and additional funding from Susan G. Komen for the Cure "to expand breast cancer awareness and prevention among the same target population of women receiving care at PEPFAR-funded HIV service sites" has allowed "the wonderfully robust PEPFAR prevention and treatment platform, considered one of the great global health achievements in recent times, to be made available to a whole new type of prevention - in this case for a non-communicable disease (NCD)."
› Verified 2 days ago
News Archive
Academic and Community Cancer Research United (ACCRU) today announced the opening of a two-arm, randomized phase III, FDA registration trial of eribulin compared to standard weekly paclitaxel as first- or second-line chemotherapy for individuals with human epidermal growth factor receptor 2 (HER2) negative, locally recurrent, unresectable or metastatic breast cancer.
Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that there was a successful auction sale of five drug program intellectual properties on September 30, 2009.
Only one in three women participating in Germany's mammography screening programme (MSP) is well-informed about it: the higher the level of education, the greater the chance of women making an informed decision.
A combination of visual training and a recently developed brain stimulation technique boosts learning in healthy adults and cortically blind patients, according to research published in JNeurosci.
In this post in the Public Health Institute's "Dialogue4Health" blog, Jeffrey Meer, director of PHI's Washington-based advocacy on global health, writes that "a significant expansion of PEPFAR's existing work to combat cervical cancer" through a partnership with the George W. Bush Institute known as Pink Ribbon Red Ribbon (PRRR); a 50 percent increase in the U.S. government's "commitment to screen and treat for this type of cancer from $20 million over five years to $30 million"; and additional funding from Susan G. Komen for the Cure "to expand breast cancer awareness and prevention among the same target population of women receiving care at PEPFAR-funded HIV service sites" has allowed "the wonderfully robust PEPFAR prevention and treatment platform, considered one of the great global health achievements in recent times, to be made available to a whole new type of prevention - in this case for a non-communicable disease (NCD)."
› Verified 2 days ago
Abingdon Family Practice Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 617 Campus Dr, Abingdon, VA 24210 Phone: 276-628-1186 Fax: 276-628-8507 | |
Empowerme Medical Group, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 860 Wolf Creek Trl, Abingdon, VA 24210 Phone: 877-367-9772 | |
Med-peds Management Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 191 Johnson St Ne, Abingdon, VA 24210 Phone: 276-623-8105 Fax: 276-623-8109 | |
Mountain Gastroenterology Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 108 Abingdon Pl, Abingdon, VA 24211 Phone: 276-623-8133 Fax: 276-623-2471 | |
Ballad Health Medical Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 16000 Johnston Memorial Dr, Fourth Floor, Abingdon, VA 24211 Phone: 276-258-4050 Fax: 276-258-4056 | |
Msmg Infectious Disease Abg Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 16000 Johnston Memorial Dr, Suite 313b, Abingdon, VA 24211 Phone: 276-258-3770 Fax: 276-258-3785 | |
Preston Square Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 24294 Teal Drive, Abingdon, VA 24211 Phone: 276-628-8303 Fax: 276-466-4815 |